Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 study of VAXCHORA in children 2 to <18 years of age
2018-003850-25Phase 3
- Sponsor
- PaxVax
- Start
- Dec 2018
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of cholera vaccine, live, oral in cholera (3 cohorts), sponsored by PaxVax. Primary endpoints: Primary immunogenicity endpoint and Safety endpoints.
02
Drugs
cholera vaccine, live, oral
03
Conditions
cholera
Beyond the preview
Go deeper on 2018-003850-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003850-25.